共 15 条
[1]
Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment, Headache, 43, pp. 36-43
[2]
El Hasnaoui A., Vray M., Blin P., Et al., Assessment of migraine severity using the MIGSEV scale: Relationship to migraine features and quality of life, Cephalalgia, 24, pp. 262-270, (2004)
[3]
Kolotylo C.J., Broome M.E., Predicting disability and quality of life in a community-based sample of women with migraine headache, Pain Manag Nurs, 1, pp. 139-151, (2000)
[4]
Lipton R.B., Liberman J.N., Kolodner K.B., Et al., Migraine headache disability and health-related quality-oflife: A population-based case-control study from England, Cephalalgia, 23, pp. 441-450, (2003)
[5]
Duru G., Auray J.P., Gaudin A.F., Et al., Impact of headache on quality of life in a general population survey in France (GRIM2000 Study), Headache, 44, pp. 571-580, (2004)
[6]
Stewart W.F., Lipton R.B., Kolodner K., Migraine disability assessment (MIDAS) score: Relation to headache frequency, pain intensity, and headache symptoms, Headache, 43, pp. 258-265, (2003)
[7]
Peters M., Abu-Saad H.H., Vydelingum V., Et al., Migraine and chronic daily headache management: A qualitative study of patients' perceptions, Scand J Caring Sci, 18, pp. 294-303, (2004)
[8]
Lipton R.B., Silberstein S.D., Saper J.R., Et al., Why headache treatment fails, Neurology, 60, pp. 1064-1070, (2003)
[9]
Lanteri-Minet M., What do patients want from their acute migraine therapy?, Eur Neurol, 53, SUPPL. 1, (2005)
[10]
Gallagher R., What do patients want from acute migraine treatment?, Cephalalgia, 24, SUPPL. 2, (2004)